Fig. 1: Flow diagram illustrating all the biomarkers of the Coca Colon cohort study. | British Journal of Cancer

Fig. 1: Flow diagram illustrating all the biomarkers of the Coca Colon cohort study.

From: CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC)

Fig. 1: Flow diagram illustrating all the biomarkers of the Coca Colon cohort study.

*Patients for which the results of circulating markers and 12-week evaluation were available. CA19-9 carbohydrate antigen 19-9, CEA carcinoembryonic antigen, cfDNA cell-free DNA, CTC circulating tumour cells, ctDNA circulating tumour DNA, WT wild type. †Kinetics were estimated for living non-progressive patients having a positive baseline value and two or three further measures at fourth cycle. ‡Only CTC baseline-positive patients underwent kinetic analysis.

Back to article page